Uusitalo H, Hiltunen A, Söderström M, Aro H T, Vuorio E
Skeletal Research Program, Department of Medical Biochemistry and Molecular Biology, University of Turku, Finland.
Calcif Tissue Int. 2000 Nov;67(5):382-90. doi: 10.1007/s002230001152.
Fracture repair provides an interesting model for chondrogenesis and osteogenesis as it recapitulates in an adult organism the same steps encountered during embryonic skeletal development and growth. The fracture callus is not only a site of rapid production of cartilage and bone, but also a site of extensive degradation of their extracellular matrices. The present study was initiated to increase our understanding of the roles of different proteolytic enzymes, cysteine cathepsins B, H, K, L, and S, and matrix metalloproteinases (MMPs) 9 and 13, during fracture repair, as this aspect of bone repair has previously received little attention. Northern analysis revealed marked upregulation of cathepsin K, MMP-9, and MMP-13 mRNAs during the first and second weeks of healing. The expression profiles of these mRNAs were similar with that of osteoclastic marker enzyme tartrate-resistant alkaline phosphatate (TRAP). The changes in the mRNA levels of cathepsins B, H, L, and S were smaller when compared with those of the other enzymes studied. Immunohistochemistry and in situ hybridization confirmed the predominant localization of cathepsin K and MMP-9 and their mRNA in osteoclasts and chondroclasts at the osteochondral junction. MMP-13 was present in osteoblasts and individual hypertrophic chondrocytes near the cartilage-bone interphase. In cartilaginous callus, the expression of cathepsins B, H, L, and S was mainly related to chondrocyte hypertrophy. During bone remodeling both osteoblasts and osteoclasts contained these cathepsins. The present data demonstrate that degradation and remodeling of extracellular matrices during fracture healing involves activation of MMP-13 production in hypertrophic chondrocytes and osteoblasts, and cathepsin K and MMP-9 production in osteoclasts and chondroclasts.
骨折修复为软骨形成和骨形成提供了一个有趣的模型,因为它在成年生物体中重现了胚胎骨骼发育和生长过程中所经历的相同步骤。骨折痂不仅是软骨和骨快速生成的部位,也是其细胞外基质广泛降解的部位。由于骨修复的这一方面此前很少受到关注,因此开展了本研究以增进我们对不同蛋白水解酶(半胱氨酸组织蛋白酶B、H、K、L和S)以及基质金属蛋白酶(MMP)9和13在骨折修复过程中作用的理解。Northern分析显示,在愈合的第一周和第二周,组织蛋白酶K、MMP-9和MMP-13的mRNA显著上调。这些mRNA的表达谱与破骨细胞标记酶抗酒石酸碱性磷酸酶(TRAP)的表达谱相似。与所研究的其他酶相比,组织蛋白酶B、H、L和S的mRNA水平变化较小。免疫组织化学和原位杂交证实,组织蛋白酶K和MMP-9及其mRNA主要定位于骨软骨交界处的破骨细胞和成软骨细胞中。MMP-13存在于软骨-骨界面附近的成骨细胞和单个肥大软骨细胞中。在软骨痂中,组织蛋白酶B、H、L和S的表达主要与软骨细胞肥大有关。在骨重塑过程中,成骨细胞和破骨细胞都含有这些组织蛋白酶。目前的数据表明,骨折愈合过程中细胞外基质的降解和重塑涉及肥大软骨细胞和成骨细胞中MMP-13生成的激活,以及破骨细胞和成软骨细胞中组织蛋白酶K和MMP-9生成的激活。